Joe Biden (Carolyn Kaster, AP Images)

Covid-19 roundup: Biden in­vests $1.7B to ad­dress Covid vari­ants; EU puts faith in Pfiz­er with new vac­cine deals

The Biden ad­min­is­tra­tion said Fri­day that it’ll pump $1.7 bil­lion in­to var­i­ous pro­grams to ad­dress Covid-19 vari­ants as the orig­i­nal strain of Covid-19 makes up on­ly about half of all US cas­es to­day.

Most of those new funds, $1 bil­lion in to­tal, will go to ex­pand ge­nom­ic se­quenc­ing so the CDC, states and oth­er ju­ris­dic­tions can im­prove their ca­pac­i­ty to iden­ti­fy Covid mu­ta­tions and mon­i­tor the cir­cu­la­tion of vari­ants. Back in Feb­ru­ary, US labs were on­ly se­quenc­ing about 8,000 Covid-19 strains per week, al­though the rate of se­quenc­ing has in­creased sub­stan­tial­ly since then, the ad­min­is­tra­tion said.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.